ARCHIVES

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

This article is from The Cancer Letter archive.

Vol. 15 No. 07 | February 17, 1989

Download PDF Visit The Full Archive

Related Articles

HEW Says Patent Delays Temporary

August 25, 1978

NCI-Approved Clinical Trials

July 29, 2005

Group Chairmen Accept Most Changes In Terms Of Award, Object To CTEP Adjustments

December 2, 1988

Senate To NCI: Return To Old Guidelines, Stop “Mixed Messages” On Mammography

February 14, 1997

Cancer Death Rates Declined 2.1 Percent Per Year.

October 19, 2007

In Brief: NCI Contract Plans Shaping Up As RFP “Season” Approaches; L-B Profit Told

September 13, 1974